H1B Report
Side-by-side comparison

APTAPHARMA, INC vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
APTAPHARMA, INC
NJRank #FEIN 20-4970367
Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAPTAPHARMA, INCDeloitte Consulting LLP
Total filings4880,813
Certified %87.50%98.23%
Denied %6.25%1.09%
Withdrawn %4.17%0.61%
Cert-withdrawn %2.08%0.07%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJPA

Outcomes — APTAPHARMA, INC

DOL case-status mix.

Outcome breakdown: Certified 87.5%, Cert-withdrawn 2.1%, Withdrawn 4.2%, Denied 6.3%
Outcome breakdown
OutcomeShare
Certified87.5%
Cert-withdrawn2.1%
Withdrawn4.2%
Denied6.3%
Certified87.5%
Cert-withdrawn2.1%
Withdrawn4.2%
Denied6.3%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

APTAPHARMA, INC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY20111
FY20120
FY20134
FY20142
FY20153
FY20169
FY20175
FY20184
FY20197
FY20200
FY20210
FY20220
FY20231
FY20242
FY20255
FY20261
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612

Top 5 occupations — APTAPHARMA, INC

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Or browse the full sponsor index.